Gan & Lee Pharmaceuticals Co Ltd (603087) — Cash Flow Reinvestment Rate

Latest as of September 2025: 1.01x

Gan & Lee Pharmaceuticals Co Ltd (603087) has a Cash Flow Reinvestment Rate of 1.01x as of September 2025, reinvesting CN¥260.89 Million (capex CN¥260.89 Million ) from operating cash flow of CN¥257.27 Million. Explore 603087 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

1.01x
(Capex + Investments) / Operating CF

Total Reinvested

CN¥260.89 Million
Capex + Investments

Operating Cash Flow

CN¥257.27 Million
CNY

Capital Expenditures

CN¥260.89 Million
CNY

Gan & Lee Pharmaceuticals Co Ltd Cash Flow Reinvestment Rate (2013–2025)

Historical reinvestment intensity for Gan & Lee Pharmaceuticals Co Ltd across 13 annual periods. Also explore Gan & Lee Pharmaceuticals Co Ltd balance sheet assets for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Gan & Lee Pharmaceuticals Co Ltd (2013–2025)

Year-by-year capital reinvestment analysis for Gan & Lee Pharmaceuticals Co Ltd. For live market cap and broader valuation context, see market cap of Gan & Lee Pharmaceuticals Co Ltd.

Year Reinvestment Rate Total Reinvested (CNY) Operating CF Capex YoY Change
2025 2.01x CN¥1.58 Billion CN¥784.28 Million CN¥926.09 Million ▲ +75.2%
2024 1.15x CN¥616.97 Million CN¥537.31 Million CN¥440.80 Million ▼ -67.9%
2023 3.58x CN¥1.53 Billion CN¥427.69 Million CN¥553.06 Million ▼ -19.1%
2022 4.42x CN¥1.31 Billion CN¥296.68 Million CN¥983.44 Million ▲ +535.4%
2021 0.70x CN¥750.31 Million CN¥1.08 Billion CN¥692.08 Million ▼ -73.4%
2020 2.61x CN¥3.24 Billion CN¥1.24 Billion CN¥582.14 Million ▲ +139.7%
2019 1.09x CN¥1.26 Billion CN¥1.15 Billion CN¥406.63 Million ▼ -31.2%
2018 1.59x CN¥662.64 Million CN¥418.04 Million CN¥513.44 Million ▲ +103.0%
2017 0.78x CN¥741.52 Million CN¥949.60 Million CN¥431.02 Million ▼ -5.1%
2016 0.82x CN¥633.34 Million CN¥769.63 Million CN¥258.48 Million ▼ -0.1%
2015 0.82x CN¥368.43 Million CN¥447.42 Million CN¥368.43 Million ▼ -20.3%
2014 1.03x CN¥315.47 Million CN¥305.22 Million CN¥315.47 Million ▲ +111.5%
2013 0.49x CN¥100.06 Million CN¥204.73 Million CN¥100.06 Million —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow